<DOC>
	<DOC>NCT00333112</DOC>
	<brief_summary>A study to evaluate solifenacin succinate in combination with tamsulosin for the treatment of residual OAB symptoms in men.</brief_summary>
	<brief_title>A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.</brief_title>
	<detailed_description>A 2 arm study ( 1 Active, 1 Placebo) to evaluate solifenacin succinate in combination with tamsulosin for the treatment of residual OAB symptoms in men</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>Symptoms of Overactive Bladder (OAB) Current use of antimuscarinic therapy Evidence of a urinary tract infection</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Treatment Outcome</keyword>
	<keyword>Urology</keyword>
	<keyword>Solifenacin succinate</keyword>
	<keyword>Urinary Incontinence</keyword>
</DOC>